Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
GSK’s overhaul begins under new CEO; Sandoz loses US$ 940 million lawsuit
This week, Phispers brings you news on GSK, whose new CEO is planning a slew of initiatives to make